Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,856
Closed -$520K 44
2020
Q4
$520K Sell
4,856
-1,226,560
-100% -$118M 0.05% 211
2020
Q3
$108M Buy
1,231,416
+1,177,017
+2,164% +$111M 1.14% 12
2020
Q2
$5.34M Buy
+54,399
New +$4.79M 0.05% 262
2020
Q1
Sell
-6,720
Closed -$594K 653
2019
Q4
$594K Sell
6,720
-136
-2% -$11.3K ﹤0.01% 444
2019
Q3
$519K Buy
6,856
+2,502
+57% +$172K ﹤0.01% 489
2019
Q2
$317K Buy
+4,354
New +$342K ﹤0.01% 562
2017
Q2
Sell
-27,612
Closed -$1.8M 567
2017
Q1
$1.8M Sell
27,612
-478
-2% -$30.1K 0.01% 370
2016
Q4
$1.76M Sell
28,090
-13,282
-32% -$811K 0.01% 366
2016
Q3
$2.61M Buy
+41,372
New +$2.68M 0.01% 328
2016
Q2
Sell
-14,028
Closed -$801K 480
2016
Q1
$801K Buy
+14,028
New +$782K ﹤0.01% 414
2015
Q3
Sell
-136,570
Closed -$9.18M 505
2015
Q2
$9.18M Sell
136,570
-36,130
-21% -$2.36M 0.04% 254
2015
Q1
$10.1M Buy
172,700
+147,900
+596% +$8.94M 0.04% 231
2014
Q4
$1.62M Hold
24,800
0.01% 351
2014
Q3
$1.43M Sell
24,800
-29,300
-54% -$1.63M 0.01% 329
2014
Q2
$3.05M Buy
+54,100
New +$2.84M 0.01% 304

Other funds holding ABBV

AJO LP's ABBV Position: Q1 2021 in Review

AJO LP sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 4,856 shares — an estimated $520K sold.

AJO LP first reported a position in ABBV in Q2 2014 and held it in 15 quarters. The position peaked at $108M in Q3 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • AJO LP reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 4,856 AbbVie shares in Q1 2021, an estimated $520K.
  • AJO LP first reported a position in AbbVie in Q2 2014 and held it in 15 quarters.
  • AJO LP's AbbVie position peaked at $108M in Q3 2020.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.